Csg Smart Science&Technology Co Current Liabilities
The Current Liabilities of Csg Smart Science&Technology Co (300222.SZ) as of Sep 8, 2026 is 2.85 B CNY. In the previous year, Current Liabilities was 3.34 B CNY — a change of -14.85% (lower).
Get this data via API
Financial Data API
Current Liabilities
2.85 BCNY
YoY
-14.85%
Last updated:
The Csg Smart Science&Technology Co Current Liabilities history
3 Years
10 Years
25 Years
Max
| YEAR | Current Liabilities | YoY |
|---|---|---|
| 2.85 BCNY | -14.85% | |
| 3.34 BCNY | -1.81% | |
| 3.41 BCNY | -9.94% | |
| 3.78 BCNY | +7.03% | |
| 3.53 BCNY | -5.50% | |
| 3.74 BCNY | +28.12% | |
| 2.92 BCNY | +74.88% | |
| 1.67 BCNY | +41.58% | |
| 1.18 BCNY | +69.68% | |
| 694.70 MCNY | +68.29% | |
| 412.80 MCNY | +195.07% | |
| 139.90 MCNY | +12.19% | |
| 124.70 MCNY | +112.80% | |
| 58.60 MCNY | -28.45% | |
| 81.90 MCNY | +75.37% | |
| 46.70 MCNY | +98.72% | |
| 23.50 MCNY | — |
Csg Smart Science&Technology Co Stock analysis
Frequently Asked Questions about Csg Smart Science&Technology Co stock
Current Liabilities of Csg Smart Science&Technology Co is 2.85 B CNY in 2026.
Current Liabilities of Csg Smart Science&Technology Co changed from 3.34 B CNY to 2.85 B CNY, representing a -14.85% change. The value is lower than the previous year.
On Eulerpool you can find the complete historical development of Current Liabilities Csg Smart Science&Technology Co since 2006 – with annual values, charts, and detailed analysis.
Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.
Current Liabilities's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Csg Smart Science&Technology Co historically and in real time.
Balance Sheet — Csg Smart Science&Technology Co
All Key Metrics — Csg Smart Science&Technology Co
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth